Vitamin D treatment distinctly modulates cytokine production by peripheral blood mononuclear cells among patients with chronic cardiac and indeterminate clinical forms of Chagas disease

Abstract Introduction Chagas disease is caused by the protozoan Trypanosoma cruzi and is clinically divided into acute and chronic phases. Chronic Chagas cardiomyopathy is the most studied manifestation of the disease. Vitamin D deficiency has been suggested as a risk factor for cardiovascular disea...

Full description

Saved in:
Bibliographic Details
Main Authors: Kamila Kássia dos Santos Oliveira, Diego José Lira Torres, Michelle da Silva Barros, Leyllane Rafael Moreira, Claudeir Dias da Silva Junior, Ana Karine de Araújo Soares, Maria da Piedade Costa Reis deAlbuquerque, Maria da Glória Aureliano Melo Cavalcante, Wilson Alves de Oliveira Junior, Michelle Christiane da Silva Rabello, Virginia Maria Barros deLorena
Format: Article
Language:English
Published: Wiley 2024-09-01
Series:Immunity, Inflammation and Disease
Subjects:
Online Access:https://doi.org/10.1002/iid3.1330
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850185099890393088
author Kamila Kássia dos Santos Oliveira
Diego José Lira Torres
Michelle da Silva Barros
Leyllane Rafael Moreira
Claudeir Dias da Silva Junior
Ana Karine de Araújo Soares
Maria da Piedade Costa Reis deAlbuquerque
Maria da Glória Aureliano Melo Cavalcante
Wilson Alves de Oliveira Junior
Michelle Christiane da Silva Rabello
Virginia Maria Barros deLorena
author_facet Kamila Kássia dos Santos Oliveira
Diego José Lira Torres
Michelle da Silva Barros
Leyllane Rafael Moreira
Claudeir Dias da Silva Junior
Ana Karine de Araújo Soares
Maria da Piedade Costa Reis deAlbuquerque
Maria da Glória Aureliano Melo Cavalcante
Wilson Alves de Oliveira Junior
Michelle Christiane da Silva Rabello
Virginia Maria Barros deLorena
author_sort Kamila Kássia dos Santos Oliveira
collection DOAJ
description Abstract Introduction Chagas disease is caused by the protozoan Trypanosoma cruzi and is clinically divided into acute and chronic phases. Chronic Chagas cardiomyopathy is the most studied manifestation of the disease. Vitamin D deficiency has been suggested as a risk factor for cardiovascular disease. No studies demonstrate the action of this hormone in the cells of patients with chronic Chagas heart disease. Objective To evaluate the in vitro immunomodulatory effect of vitamin D on peripheral blood mononuclear cells of patients with the different chronic clinical forms of Chagas disease. Evaluating vitamin D's in vitro effect on blood cells by producing cytokines. Methods Thirteen patients of the undetermined form (IND), 13 of the mild cardiac form (CARD1) and 14 of the severe cardiac form (CARD2) of Chagas disease, and 12 with idiopathic heart disease (CARDid) were included. The cells obtained from peripheral blood were treated in vitro with vitamin D (1 × 10−7 M) for 24 h and cytokines were dosed in the culture supernatant. Results Although it was not possible to demonstrate statistically significant differences between the groups studied, our data showed that the cells treated with vitamin D modify (p < .05) the production of interferon‐γ (IFN‐γ) (decrease in IND), tumor necrosis factor‐α (TNF‐α) (decreased in CARD1 and CARDid), interleukin (IL)‐6 (increased in all groups), and IL‐10 (decreased in CARD1, CARD2, and CARDid) when compared to untreated cells. Conclusion In vitro treatment with vitamin D distinctly modulated the production of cytokines by mononuclear cells of peripheral blood among patients with chronic and indeterminate cardiac clinical forms of Chagas disease.
format Article
id doaj-art-73a2f14665b74f2bbb0c7504cc4625ac
institution OA Journals
issn 2050-4527
language English
publishDate 2024-09-01
publisher Wiley
record_format Article
series Immunity, Inflammation and Disease
spelling doaj-art-73a2f14665b74f2bbb0c7504cc4625ac2025-08-20T02:16:50ZengWileyImmunity, Inflammation and Disease2050-45272024-09-01129n/an/a10.1002/iid3.1330Vitamin D treatment distinctly modulates cytokine production by peripheral blood mononuclear cells among patients with chronic cardiac and indeterminate clinical forms of Chagas diseaseKamila Kássia dos Santos Oliveira0Diego José Lira Torres1Michelle da Silva Barros2Leyllane Rafael Moreira3Claudeir Dias da Silva Junior4Ana Karine de Araújo Soares5Maria da Piedade Costa Reis deAlbuquerque6Maria da Glória Aureliano Melo Cavalcante7Wilson Alves de Oliveira Junior8Michelle Christiane da Silva Rabello9Virginia Maria Barros deLorena10Institute Aggeu Magalhães, Laboratory of Immunoparasitology Oswaldo Cruz Foundation‐FIOCRUZ Recife Pernambuco BrazilInstitute Aggeu Magalhães, Laboratory of Immunoparasitology Oswaldo Cruz Foundation‐FIOCRUZ Recife Pernambuco BrazilInstitute Aggeu Magalhães, Laboratory of Immunoparasitology Oswaldo Cruz Foundation‐FIOCRUZ Recife Pernambuco BrazilInstitute Aggeu Magalhães, Laboratory of Immunoparasitology Oswaldo Cruz Foundation‐FIOCRUZ Recife Pernambuco BrazilInstitute Aggeu Magalhães, Laboratory of Immunoparasitology Oswaldo Cruz Foundation‐FIOCRUZ Recife Pernambuco BrazilAltino Ventura Foundation (FAV) Recife Pernambuco BrazilChagas disease and Heart Failure Outpatient Clinic of the Pronto Socorro Cardiológico de Pernambuco University of Pernambuco (UPE) Recife Pernambuco BrazilChagas disease and Heart Failure Outpatient Clinic of the Pronto Socorro Cardiológico de Pernambuco University of Pernambuco (UPE) Recife Pernambuco BrazilChagas disease and Heart Failure Outpatient Clinic of the Pronto Socorro Cardiológico de Pernambuco University of Pernambuco (UPE) Recife Pernambuco BrazilInstitute Aggeu Magalhães, Laboratory of Immunoparasitology Oswaldo Cruz Foundation‐FIOCRUZ Recife Pernambuco BrazilInstitute Aggeu Magalhães, Laboratory of Immunoparasitology Oswaldo Cruz Foundation‐FIOCRUZ Recife Pernambuco BrazilAbstract Introduction Chagas disease is caused by the protozoan Trypanosoma cruzi and is clinically divided into acute and chronic phases. Chronic Chagas cardiomyopathy is the most studied manifestation of the disease. Vitamin D deficiency has been suggested as a risk factor for cardiovascular disease. No studies demonstrate the action of this hormone in the cells of patients with chronic Chagas heart disease. Objective To evaluate the in vitro immunomodulatory effect of vitamin D on peripheral blood mononuclear cells of patients with the different chronic clinical forms of Chagas disease. Evaluating vitamin D's in vitro effect on blood cells by producing cytokines. Methods Thirteen patients of the undetermined form (IND), 13 of the mild cardiac form (CARD1) and 14 of the severe cardiac form (CARD2) of Chagas disease, and 12 with idiopathic heart disease (CARDid) were included. The cells obtained from peripheral blood were treated in vitro with vitamin D (1 × 10−7 M) for 24 h and cytokines were dosed in the culture supernatant. Results Although it was not possible to demonstrate statistically significant differences between the groups studied, our data showed that the cells treated with vitamin D modify (p < .05) the production of interferon‐γ (IFN‐γ) (decrease in IND), tumor necrosis factor‐α (TNF‐α) (decreased in CARD1 and CARDid), interleukin (IL)‐6 (increased in all groups), and IL‐10 (decreased in CARD1, CARD2, and CARDid) when compared to untreated cells. Conclusion In vitro treatment with vitamin D distinctly modulated the production of cytokines by mononuclear cells of peripheral blood among patients with chronic and indeterminate cardiac clinical forms of Chagas disease.https://doi.org/10.1002/iid3.1330Chagas diseaseimmune responsevitamin D
spellingShingle Kamila Kássia dos Santos Oliveira
Diego José Lira Torres
Michelle da Silva Barros
Leyllane Rafael Moreira
Claudeir Dias da Silva Junior
Ana Karine de Araújo Soares
Maria da Piedade Costa Reis deAlbuquerque
Maria da Glória Aureliano Melo Cavalcante
Wilson Alves de Oliveira Junior
Michelle Christiane da Silva Rabello
Virginia Maria Barros deLorena
Vitamin D treatment distinctly modulates cytokine production by peripheral blood mononuclear cells among patients with chronic cardiac and indeterminate clinical forms of Chagas disease
Immunity, Inflammation and Disease
Chagas disease
immune response
vitamin D
title Vitamin D treatment distinctly modulates cytokine production by peripheral blood mononuclear cells among patients with chronic cardiac and indeterminate clinical forms of Chagas disease
title_full Vitamin D treatment distinctly modulates cytokine production by peripheral blood mononuclear cells among patients with chronic cardiac and indeterminate clinical forms of Chagas disease
title_fullStr Vitamin D treatment distinctly modulates cytokine production by peripheral blood mononuclear cells among patients with chronic cardiac and indeterminate clinical forms of Chagas disease
title_full_unstemmed Vitamin D treatment distinctly modulates cytokine production by peripheral blood mononuclear cells among patients with chronic cardiac and indeterminate clinical forms of Chagas disease
title_short Vitamin D treatment distinctly modulates cytokine production by peripheral blood mononuclear cells among patients with chronic cardiac and indeterminate clinical forms of Chagas disease
title_sort vitamin d treatment distinctly modulates cytokine production by peripheral blood mononuclear cells among patients with chronic cardiac and indeterminate clinical forms of chagas disease
topic Chagas disease
immune response
vitamin D
url https://doi.org/10.1002/iid3.1330
work_keys_str_mv AT kamilakassiadossantosoliveira vitamindtreatmentdistinctlymodulatescytokineproductionbyperipheralbloodmononuclearcellsamongpatientswithchroniccardiacandindeterminateclinicalformsofchagasdisease
AT diegojoseliratorres vitamindtreatmentdistinctlymodulatescytokineproductionbyperipheralbloodmononuclearcellsamongpatientswithchroniccardiacandindeterminateclinicalformsofchagasdisease
AT michelledasilvabarros vitamindtreatmentdistinctlymodulatescytokineproductionbyperipheralbloodmononuclearcellsamongpatientswithchroniccardiacandindeterminateclinicalformsofchagasdisease
AT leyllanerafaelmoreira vitamindtreatmentdistinctlymodulatescytokineproductionbyperipheralbloodmononuclearcellsamongpatientswithchroniccardiacandindeterminateclinicalformsofchagasdisease
AT claudeirdiasdasilvajunior vitamindtreatmentdistinctlymodulatescytokineproductionbyperipheralbloodmononuclearcellsamongpatientswithchroniccardiacandindeterminateclinicalformsofchagasdisease
AT anakarinedearaujosoares vitamindtreatmentdistinctlymodulatescytokineproductionbyperipheralbloodmononuclearcellsamongpatientswithchroniccardiacandindeterminateclinicalformsofchagasdisease
AT mariadapiedadecostareisdealbuquerque vitamindtreatmentdistinctlymodulatescytokineproductionbyperipheralbloodmononuclearcellsamongpatientswithchroniccardiacandindeterminateclinicalformsofchagasdisease
AT mariadagloriaaurelianomelocavalcante vitamindtreatmentdistinctlymodulatescytokineproductionbyperipheralbloodmononuclearcellsamongpatientswithchroniccardiacandindeterminateclinicalformsofchagasdisease
AT wilsonalvesdeoliveirajunior vitamindtreatmentdistinctlymodulatescytokineproductionbyperipheralbloodmononuclearcellsamongpatientswithchroniccardiacandindeterminateclinicalformsofchagasdisease
AT michellechristianedasilvarabello vitamindtreatmentdistinctlymodulatescytokineproductionbyperipheralbloodmononuclearcellsamongpatientswithchroniccardiacandindeterminateclinicalformsofchagasdisease
AT virginiamariabarrosdelorena vitamindtreatmentdistinctlymodulatescytokineproductionbyperipheralbloodmononuclearcellsamongpatientswithchroniccardiacandindeterminateclinicalformsofchagasdisease